// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























45280 Abstracts

Day-1 post-operative alt does not predict morbidity following liver resection – Analysis of a contemporary cohort of 110 patients

A. Nair - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

EGFR ligand expression levels and detriment from cetuximab in patients with operable liver metastases from colorectal cancer

S.A. Pugh - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal Cancer

Erbitux

Primary liver resection for patients with cirrhosis and hepatocellular carcinoma: Outcomes in a liver transplant unit

R. Bell - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Preoperative peripheral blood monocyte count is not associated with long term outcomes following resection for colorectal liver metastasis (CRLM)

R. Thethi - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Ablation for recurrent hepatocellular carcinoma: A systematic review of clinical efficacy and prognostic factors

S. Thomasset - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Changing trends in the presentation of colorectal liver metastases in a single hepatobiliary tertiary referral centre over fourteen years

S. Thomasset - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

The ongoing effects of enhanced recovery for liver resectional surgery

R. Gordon - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Margin status is a predictor of long-term survival following resection of non-colorectal, non-net liver metastases

B.V. Dasari - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Secondary liver cancer

N/A

Is an upper midline incision a suitable incision for major liver resections?

R. Orti-Rodriguez - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Combined hepatocellular carcinoma and cholangiocarcinoma: Clinical radiological, histopathological features and treatment outcomes

S. Farid - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Liver cancer

N/A

Impact of socioeconomic deprivation on outcomes after resection of colorectal liver metastases

N. Swetenham - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Comparison of the prognostic value of systemic inflammatory indices in patients with resectable colorectal liver metastases

C.P. Neal - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Repeat hepatic resection for recurrent colorectal liver metastase Evaluation of short-term and long-term outcomes

C.P. Neal - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

Outcomes after portal vein embolization in South Wales

M.C. Mortimer - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

What are the long- and short-term effects of polymorbidity following resection for colorectal liver metastases?

A. Al Duwaisan - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Impact of colorectal cancer primary node status on survival following colorectal liver metastases resection

S. Pathak - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Impact of advancing age on recurrence and survival following major hepatectomy for CRLM

R. Bell - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

A comparison of open and percutaneous radiofrequency ablation strategies for the management of colorectal liver metastases

J. Skipworth - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Indeterminate pulmonary nodules in colorectal liver metastase A comparison of patient outcomes

V. Robertson - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Colorectal liver metastases

N/A

Impact of liver metastases on survival following surgery for locally recurrent rectal cancer

N. Kimura - International Hepato-Pancreato-Biliary Association (IHPBA) , 2016

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

Secondary liver cancer

N/A

Copyright © 2026. QuantiNova All rights reserved